Advertisement
Screener

CURIS, INC. (CRIS) Earnings Per Share, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

CURIS, INC. Earnings Per Share, Basic and Diluted

CURIS, INC. (CRIS) reported Earnings Per Share, Basic and Diluted of -$0.11 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-16.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-16

  • CURIS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.11.
  • CURIS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.11.
  • CURIS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.17.
  • CURIS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.28.
  • CURIS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.61.
  • CURIS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.97.
  • CURIS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.98.
  • CURIS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.79.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 6 month as first filedEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 monthEarnings Per Share, Basic and Diluted 12 month as first filed
2020-12-31-$0.11
10-K · filed 2021-03-16
-$0.22
derived: net income ÷ weighted average shares · filed 2021-11-09
-$0.38
derived: net income ÷ weighted average shares · filed 2021-11-09
-$0.61
10-K · filed 2021-03-16
2020-09-30-$0.11
10-K · filed 2021-03-16
-$0.27
derived: net income ÷ weighted average shares · filed 2021-11-09
-$0.52
10-Q · filed 2020-11-10
-$0.77
derived: net income ÷ weighted average shares · filed 2021-11-09
2020-06-30-$0.17
10-K · filed 2021-03-16
-$0.44
10-Q · filed 2020-08-04
-$0.70
derived: net income ÷ weighted average shares · filed 2021-11-09
-$0.90
derived: net income ÷ weighted average shares · filed 2021-11-09
2020-03-31-$0.28
10-K · filed 2021-03-16
-$0.54
derived: net income ÷ weighted average shares · filed 2021-11-09
-$0.74
derived: net income ÷ weighted average shares · filed 2021-11-09
-$0.95
derived: net income ÷ weighted average shares · filed 2021-11-09
2019-12-31-$0.26
10-K · filed 2021-03-16
-$0.45
derived: net income ÷ weighted average shares · filed 2021-03-16
-$0.67
derived: net income ÷ weighted average shares · filed 2021-03-16
-$0.97
10-K · filed 2021-03-16
2019-09-30-$0.19
10-K · filed 2021-03-16
-$0.41
derived: net income ÷ weighted average shares · filed 2021-03-16
-$0.71
10-Q · filed 2020-11-10
-$0.89
derived: net income ÷ weighted average shares · filed 2021-03-16
2019-06-30-$0.22
10-K · filed 2021-03-16
-$0.52
10-Q · filed 2020-08-04
-$0.70
derived: net income ÷ weighted average shares · filed 2021-03-16
-$0.91
derived: net income ÷ weighted average shares · filed 2021-03-16
2019-03-31-$0.30
10-K · filed 2021-03-16
-$0.48
derived: net income ÷ weighted average shares · filed 2021-03-16
-$0.70
derived: net income ÷ weighted average shares · filed 2021-03-16
-$0.96
derived: net income ÷ weighted average shares · filed 2021-03-16
2018-12-31-$0.18
10-K · filed 2020-03-19
-$0.40
derived: net income ÷ weighted average shares · filed 2020-03-19
-$0.66
derived: net income ÷ weighted average shares · filed 2020-03-19
-$0.98
10-K · filed 2020-03-19
2018-09-30-$0.22
10-K · filed 2020-03-19
-$0.48
derived: net income ÷ weighted average shares · filed 2020-03-19
-$0.80
10-Q · filed 2019-11-05
-$1.05
derived: net income ÷ weighted average shares · filed 2020-03-19
2018-06-30-$0.26
10-K · filed 2020-03-19
-$0.59
10-Q · filed 2019-08-09
-$0.83
derived: net income ÷ weighted average shares · filed 2020-03-19
-$1.34
derived: net income ÷ weighted average shares · filed 2020-03-19
2018-03-31-$0.33
10-K · filed 2020-03-19
-$0.07
10-Q · filed 2018-05-03
-$0.57
derived: net income ÷ weighted average shares · filed 2020-03-19
-$1.08
derived: net income ÷ weighted average shares · filed 2020-03-19
-$1.56
derived: net income ÷ weighted average shares · filed 2020-03-19
2017-12-31-$0.24
10-K · filed 2019-03-26
-$0.05
10-K · filed 2018-03-08
-$0.76
derived: net income ÷ weighted average shares · filed 2019-03-26
-$1.24
derived: net income ÷ weighted average shares · filed 2019-03-26
-$1.79
10-K · filed 2019-03-26
-$0.36
10-K · filed 2018-03-08
2017-09-30-$0.53
10-K · filed 2019-03-26
-$0.11
10-Q · filed 2017-11-07
-$1.02
derived: net income ÷ weighted average shares · filed 2019-03-26
-$1.57
10-Q · filed 2018-11-01
-$0.31
10-Q · filed 2017-11-07
-$1.00
derived: net income ÷ weighted average shares · filed 2019-03-26
2017-06-30-$0.49
10-K · filed 2019-03-26
-$0.10
10-Q · filed 2017-08-03
-$1.04
10-Q · filed 2018-08-02
-$0.21
10-Q · filed 2017-08-03
-$0.62
derived: net income ÷ weighted average shares · filed 2019-03-26
-$0.84
derived: net income ÷ weighted average shares · filed 2019-03-26
2017-03-31-$0.55
10-K · filed 2019-03-26
-$0.11
10-Q · filed 2017-05-04
-$0.32
derived: net income ÷ weighted average shares · filed 2019-03-26
-$0.55
derived: net income ÷ weighted average shares · filed 2019-03-26
-$0.62
derived: net income ÷ weighted average shares · filed 2019-03-26
2016-12-31-$0.08
10-K · filed 2018-03-08
-$0.29
derived: net income ÷ weighted average shares · filed 2018-03-08
-$0.38
derived: net income ÷ weighted average shares · filed 2018-03-08
-$0.45
10-K · filed 2018-03-08
2016-09-30-$0.21
10-K · filed 2018-03-08
-$0.30
derived: net income ÷ weighted average shares · filed 2018-03-08
-$0.38
10-Q · filed 2017-11-07
-$0.48
derived: net income ÷ weighted average shares · filed 2018-03-08
2016-06-30-$0.09
10-K · filed 2018-03-08
-$0.16
10-Q · filed 2017-08-03
-$0.27
derived: net income ÷ weighted average shares · filed 2018-03-08
-$0.31
derived: net income ÷ weighted average shares · filed 2018-03-08
2016-03-31-$0.07
10-K · filed 2018-03-08
-$0.18
derived: net income ÷ weighted average shares · filed 2018-03-08
-$0.22
derived: net income ÷ weighted average shares · filed 2018-03-08
-$0.28
derived: net income ÷ weighted average shares · filed 2018-03-08
2015-12-31-$0.10
10-K · filed 2017-03-09
-$0.15
derived: net income ÷ weighted average shares · filed 2017-03-09
-$0.21
derived: net income ÷ weighted average shares · filed 2017-03-09
-$0.48
10-K · filed 2018-03-08
2015-09-30-$0.04
10-K · filed 2017-03-09
-$0.11
derived: net income ÷ weighted average shares · filed 2017-03-09
-$0.37
10-Q · filed 2016-11-03
-$0.45
derived: net income ÷ weighted average shares · filed 2017-03-09
2015-06-30-$0.06
10-K · filed 2017-03-09
-$0.34
10-Q · filed 2016-08-04
-$0.43
derived: net income ÷ weighted average shares · filed 2017-03-09
-$0.50
derived: net income ÷ weighted average shares · filed 2017-03-09
2015-03-31-$0.30
10-K · filed 2017-03-09
-$0.39
derived: net income ÷ weighted average shares · filed 2017-03-09
-$0.46
derived: net income ÷ weighted average shares · filed 2017-03-09
-$0.49
derived: net income ÷ weighted average shares · filed 2017-03-09
2014-12-31-$0.07
10-K · filed 2016-02-29
-$0.13
derived: net income ÷ weighted average shares · filed 2016-02-29
-$0.15
derived: net income ÷ weighted average shares · filed 2016-02-29
-$0.22
10-K · filed 2017-03-09
2014-09-30-$0.06
10-K · filed 2016-02-29
-$0.09
derived: net income ÷ weighted average shares · filed 2016-02-29
-$0.15
10-Q · filed 2015-11-09
-$0.20
derived: net income ÷ weighted average shares · filed 2016-02-29
2014-06-30-$0.02
10-K · filed 2016-02-29
-$0.09
10-Q · filed 2015-08-06
-$0.14
derived: net income ÷ weighted average shares · filed 2016-02-29
-$0.16
derived: net income ÷ weighted average shares · filed 2016-02-29
2014-03-31-$0.06
10-K · filed 2016-02-29
-$0.11
derived: net income ÷ weighted average shares · filed 2016-02-29
-$0.14
derived: net income ÷ weighted average shares · filed 2016-02-29
-$0.15
derived: net income ÷ weighted average shares · filed 2016-02-29
2013-12-31-$0.05
10-K · filed 2015-02-24
-$0.07
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.09
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.15
10-K · filed 2016-02-29
2013-09-30-$0.02
10-Q · filed 2014-11-10
-$0.04
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.10
10-Q · filed 2014-11-10
-$0.25
derived: net income ÷ weighted average shares · filed 2015-02-24
2013-06-30-$0.02
10-K · filed 2015-02-24
-$0.08
10-Q · filed 2014-08-07
-$0.23
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.27
derived: net income ÷ weighted average shares · filed 2015-02-24
2013-03-31-$0.06
10-K · filed 2015-02-24
-$0.22
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.26
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.30
derived: net income ÷ weighted average shares · filed 2015-02-24
2012-12-31-$0.15
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.20
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.23
derived: net income ÷ weighted average shares · filed 2015-02-24
-$0.21
10-K · filed 2015-02-24
2012-09-30-$0.04
10-Q · filed 2013-11-12
-$0.08
derived: net income ÷ weighted average shares · filed 2014-03-13
-$0.05
10-Q · filed 2013-11-12
2012-06-30-$0.04
10-Q · filed 2013-08-08
-$0.01
10-Q · filed 2013-08-08
2011-12-31$0.08
derived: net income ÷ weighted average shares · filed 2014-03-13
$0.02
derived: net income ÷ weighted average shares · filed 2014-03-13
-$0.04
derived: net income ÷ weighted average shares · filed 2014-03-13
-$0.13
10-K · filed 2014-03-13
2011-09-30-$0.05
10-Q · filed 2012-11-06
-$0.12
derived: net income ÷ weighted average shares · filed 2013-03-13
-$0.21
10-Q · filed 2012-11-06
2011-06-30-$0.06
10-Q · filed 2012-08-09
-$0.15
10-Q · filed 2012-08-09
2010-12-31-$0.06
10-K · filed 2013-03-13
2009-12-31-$0.15
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70